Nat Med. 2014 Apr;20(4):325. doi: 10.1038/nm0414-325.
For more than four decades, the US Institute of Medicine (IOM) has operated as an independent nonprofit organization with a mission of providing guiding documents on matters of health and biomedical research, many of which are commissioned by the government. The IOM--part of the 151-year-old National Academy of Sciences--issues reports on a wide range of topics, from salt consumption to clinical trial data sharing, and convenes workshops at its headquarters in Washington, DC.The institute counts almost 2,000 experts among its members, including Victor Dzau. On 1 July, Dzau will replace health policy expert Harvey Fineberg as president of the IOM for a six-year term. A cardiologist and researcher by training, Dzau currently serves as chancellor for health affairs at Duke University in Durham, North Carolina. During his time at Duke, he has broadened the reach of the institution by helping to launch the Duke-National University of Singapore Graduate Medical School, the Duke Global Health Institute and the International Partnership for Innovative Healthcare Delivery. Roxanne Khamsi spoke with Dzau about his vision for the IOM. The conversation has been edited for clarity.
四十多年来，美国医学研究所（IOM）一直作为一个独立的非营利组织运作，其使命是提供关于健康和生物医学研究的指导文件，其中许多文件都是受政府委托的。IOM 是拥有 151 年历史的美国国家科学院的一部分，它发布了从盐摄入量到临床试验数据共享等广泛主题的报告，并在其位于华盛顿特区的总部举办研讨会。该研究所拥有近 2000 名专家成员，其中包括 Victor Dzau。7 月 1 日，Dzau 将接替卫生政策专家 Harvey Fineberg 担任 IOM 主席，任期六年。作为一名心脏病学家和研究员，Dzau 目前在北卡罗来纳州达勒姆的杜克大学担任卫生事务校长。在杜克大学期间，他通过帮助建立杜克-新加坡国立大学研究生院、杜克全球健康研究所和国际创新医疗交付伙伴关系，扩大了该机构的影响力。Roxanne Khamsi 采访了 Dzau，了解他对 IOM 的愿景。对话经过了编辑，以使其更清晰。
